Alpha Omega Wealth Management’s GSK GSK Stock Holding History

Alpha Omega Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-437	Closed	-$22K	–	359
2019 Q2	$22K	Buy	+437	New	+$21.9K	0.01%	349
2018 Q4	–	Sell	-100	Closed	-$5K	–	477
2018 Q3	$5K	Hold	100	–	–	﹤0.01%	424
2018 Q2	$5K	Hold	100	–	–	﹤0.01%	430
2018 Q1	$5K	Sell	100 -220	-69%	-$10.2K	﹤0.01%	404
2017 Q4	$14K	Hold	320	–	–	0.01%	319
2017 Q3	$16K	Hold	320	–	–	0.01%	314
2017 Q2	$17K	Sell	320 -96	-23%	-$5.12K	0.01%	302
2017 Q1	$22K	Buy	416 +1	+0.2%	+$51	0.01%	283
2016 Q4	$20K	Buy	415 +321	+341%	+$15.9K	0.01%	289
2016 Q3	$5K	Buy	94 +1	+1%	+$55	﹤0.01%	188
2016 Q2	$5K	Buy	93 +2	+2%	+$105	﹤0.01%	194
2016 Q1	$5K	Buy	91 +1	+1%	+$50	﹤0.01%	193
2015 Q4	$5K	Buy	+90	New	+$4.59K	﹤0.01%	185

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Alpha Omega Wealth Management's GSK Position: Q3 2019 in Review

Alpha Omega Wealth Management sold out of GSK (GSK) in Q3 2019, closing a stake of 437 shares — an estimated $22K sold.

Alpha Omega Wealth Management first reported a position in GSK in Q4 2015 and held it in 13 quarters. The position peaked at $22K in Q2 2019. 805 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

Alpha Omega Wealth Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
Alpha Omega Wealth Management sold 437 GSK shares in Q3 2019, an estimated $22K.
Alpha Omega Wealth Management first reported a position in GSK in Q4 2015 and held it in 13 quarters.
Alpha Omega Wealth Management's GSK position peaked at $22K in Q2 2019.
805 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Alpha Omega Wealth Management's 13F filing for Q3 2019, filed 12 Nov 2019.